[Corrigendum] Effect of duty cycles of tumor‑treating fields on glioblastoma cells and normal brain organoids

• Authors:
  • Eunbi Ye
  • Jung Eun Lee
  • Young-Soo Lim
  • Seung Ho Yang
  • Sung-Min Park

• View Affiliations

  
  Affiliations: Department of Convergence IT Engineering, Pohang University of Science and Technology, Pohang‑si, Gyeongsangbuk‑do 37673, Republic of Korea, Department of Neurosurgery, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon‑si, Gyeonggi‑do 16247, Republic of Korea
• Published online on: July 25, 2022     https://doi.org/10.3892/ijo.2022.5397
• Article Number: 107

• Copyright : © Ye et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Article

Int J Oncol 60: [Related article:] 8, 2022; DOI: 10.3892/ijo.2021.5298

Subsequently to the publication of the above article, the authors have realized that Fig. 3 on p. 6, showing the results of bioluminescence imaging of U87 and U373 cells after applying tumor-treating fields for 72 h, was published containing an erroneous image. Essentially, the data analysis panel for the U87 / U87TTF experiment was inadvertently copied across for the U373 / U373TTF experiment for the '75% Duty' experimental condition.

Figure 3 Bioluminescence imaging of U87 and U373 cells after applying tumor-treating fields for 72 h. Data are presented as the average ± SD (n=5). *P<0.001 and **P<0.05. For the U87TTF and U373TTF experiments, 'TTF' indicates 'treated with tumor-treating fields'.

The revised version of Fig. 3, now showing the correct data analysis panel for the '75% Duty' U373 / U373TTF experiment, is shown below. The authors confirm that the error made in the presentation of Fig. 3 did not adversely affect the conclusions reported in this paper, and they are grateful to the Editor of International Journal of Oncology for granting them this opportunity to publish a Corrigendum. All the authors agree to the publication of this Corrigendum; they also apologize to the readership for any inconvenience caused.

Figure 3 Bioluminescence imaging of U87 and U373 cells after applying tumor-treating fields for 72 h. Data are presented as the average ± SD (n=5). *P<0.001 and **P<0.05. For the U87TTF and U373TTF experiments, 'TTF' indicates 'treated with tumor-treating fields'.